ananthi, Author at Sun Pharmaceutical Industries Ltd. - Page 4 of 4

Press Release Completion of Checkpoint Acquisition

Press Release Completion of Checkpoint Acquisition

by ananthi | May 30, 2025 | Press Releases

Read More

Sun Pharma reports Q4 and full year results for FY25

Sun Pharma reports Q4 and full year results for FY25

by ananthi | May 22, 2025 | Press Releases

Read More

Sun Pharma Launches Corporate Brand Campaign in India

by ananthi | May 6, 2025 | Uncategorized

Read More

Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage

Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage

by ananthi | May 6, 2025 | Uncategorized

Read More

Sun Pharma introduces a novel class of drug, Fexuclue®(Fexuprazan) in India for treatment of Erosive Esophagitis

Sun Pharma introduces a novel class of drug, Fexuclue®(Fexuprazan) in India for treatment of Erosive Esophagitis

by ananthi | May 6, 2025 | Uncategorized

Read More

Next Entries »

Top